- Tytuł:
- Safety and immunogenicity of the two-dose heterologous Ad26.ZEBOV and MVA-BN-Filo Ebola vaccine regimen in infants: a phase 2, randomised, double-blind, active-controlled trial in Guinea and Sierra Leone
- Autorzy:
- Źródło:
- In The Lancet Global Health November 2023 11(11):e1743-e1752
Czasopismo naukowe